Safety and Immunogenicity of 3 Lots of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Volunteers ≥ 15y
Clinical trial NCT00696917 · COMPLETED
Trial details
- NCT number
- NCT00696917
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1999-04-01
- Primary completion
- 2000-02-01
- Enrollment
- 1303
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.